3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase 2
3
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Lymphoma, Large B-Cell, Diffuse
9
Hodgkin Disease
7
Sarcoma
6
Lymphoma
6
Testicular Neoplasms
5
Testicular Germ Cell Tumor
5
Ovarian Neoplasms
5
Osteosarcoma
5
Lymphoma, Follicular
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Anaplastic
4
Burkitt Lymphoma
4
Recurrence
3
Lymphoma, Large-Cell, Immunoblastic
3
Immunoblastic Lymphadenopathy
3
Central Nervous System Neoplasms
3
Waldenstrom Macroglobulinemia
2
Teratoma
2
Solitary Fibrous Tumors
2
Small Cell Lung Carcinoma
2
Sarcoma, Clear Cell
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hemangiosarcoma
2
Hemangioendothelioma, Epithelioid
2
Dendritic Cell Sarcoma, Interdigitating
2
Interventions
pegfilgrastim
1
Paclitaxel
1
Lenograstim
1
Ifosfamide
1
Gemcitabine
1
Filgrastim
1
Cisplatin
1
Beclomethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Seminoma
×
Ifosfamide
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled